بدائل البحث:
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
i values » _ values (توسيع البحث)
b large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), i large (توسيع البحث)
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
i values » _ values (توسيع البحث)
b large » _ large (توسيع البحث), a large (توسيع البحث), _ larger (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), i large (توسيع البحث)
-
81
Histogram of day-of-year for sample collection for data collected for this meta-analysis.
منشور في 2025الموضوعات: -
82
Quantification of isotopic niche overlap for feeding habits between coastscapes.
منشور في 2025الموضوعات: -
83
-
84
-
85
-
86
-
87
-
88
Dynamical features of spontaneous firing activity in the one-cortical-column model.
منشور في 2025"…Refer <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013398#pcbi.1013398.t001" target="_blank">Tables 1</a> and <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013398#pcbi.1013398.t002" target="_blank">2</a> for parameter description and values, respectively. …"
-
89
-
90
-
91
-
92
-
93
-
94
-
95
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
منشور في 2025"…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …"
-
96
Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …"
-
97
Data Sheet 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …"
-
98
-
99
-
100